Summary:
Investigators Research Group is conducting a Randomized, Double-Blind, Parallel-Group, Placebo-Controlled, Multi-Dose Study of Two Dosage Strengths of Study Drug compared with Placebo with Patients with Irritable Bowel Syndrome with Constipation (IBS-C).
Qualified Participants Must:
• Be between 18 and 65 year of age
•
Be diagnosed with IBS-C
•
Have constipation for 6 months or longer
Have less than 3 bowel movements per week
•
Have abdominal pain associated with IBS-C
•
Not have any other bowel disorders or conditions
Qualified Participants May Receive:
Study IBS-C Medication, Study related exams, labs, test and supplies, and Compensation at every visit up to $525.00